SCHEDULE 13G MARK J SILVERMAN

Company

GT Biopharma, Inc.

Filed

December 4, 2017

Accession Number

0000939798-17-000104

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →